Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplanta

Go back to Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplanta
(NASDAQ: SANA) Delayed: 3.10 --0 (-0%)
Previous Close $3.10    52 Week High
Open $3.10    52 Week Low
Day High $3.10    P/E N/A 
Day Low $3.10    EPS
Volume 5,243